Provided by Tiger Trade Technology Pte. Ltd.

Carpenter Technology

476.42
-0.01000.00%
Post-market: 476.420.00000.00%19:30 EDT
Volume:4.02M
Turnover:1.91B
Market Cap:23.61B
PE:45.29
High:481.17
Open:477.43
Low:465.02
Close:476.43
52wk High:625.99
52wk Low:228.00
Shares:49.56M
Float Shares:48.15M
Volume Ratio:6.82
T/O Rate:8.35%
Dividend:0.80
Dividend Rate:0.17%
EPS(TTM):10.52
EPS(LYR):10.52
ROE:25.75%
ROA:11.87%
PB:10.60
PE(LYR):45.29

Loading ...

Antengene Appoints Dr. Bing Hou as Chief Scientific Officer to Lead Innovation-Driven R&D Strategy and Advance Next-Generation Pipeline

prnewswire
·
May 20

J.P. Morgan Remains a Buy on Carpenter Technology (CRS)

TIPRANKS
·
May 19

Press Release: Tempest Reports First Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
May 15

Autolus Therapeutics Reports First Quarter 2026 Financial Results and Business Updates

GlobeNewswire
·
May 14

Cabaletta Bio Presents Preconditioning-free Clinical Data and Automated Manufacturing Translational Data for Rese-cel at ASGCT 2026 Annual Meeting

GlobeNewswire
·
May 14

Allogene Therapeutics Reports First Quarter 2026 Financial Results and Business Update

GlobeNewswire
·
May 14

Trump's 'Gold Dome' Missile Defense Plan Could Cost $1.2 Trillion Over 20 Years, Report Finds

Deep News
·
May 13

Poolbeg to Showcase POLB 001 CRS Data at Major Hematology Congress

TIPRANKS
·
May 13

Kyverna Therapeutics Announces Initiation of Rolling SPS BLA Submission and Reports First Quarter 2026 Financial Results

GlobeNewswire
·
May 13

Cellectis Reports Financial Results for the First Quarter 2026

GlobeNewswire
·
May 12

Poolbeg Pharma Wins Canadian Patent for POLB 001 in Cancer CRS Prevention

TIPRANKS
·
May 11

Artiva Announces Positive Initial Clinical Data with AlloNK® Across Multiple Autoimmune Diseases and FDA Alignment to Initiate Phase 3 Registrational Trial in Rheumatoid Arthritis in 2026

GlobeNewswire
·
May 08

Press Release: IN8bio Reports First Quarter 2026 Financial Results and Recent Business Highlights

Dow Jones
·
May 08

Carpenter Tech Director John Anastasios Hart disposes of shares worth $317,896.58

Reuters
·
May 07

Carpenter Tech VP Marshall D. Akins sells shares worth $4.79 million

Reuters
·
May 07

Immunocore reports first quarter financial results and provides a business update

GlobeNewswire
·
May 06

Carpenter Tech Is Maintained at Overweight by Keybanc

Dow Jones
·
May 04

Analysts’ Opinions Are Mixed on These Industrial Goods Stocks: Adt (ADT) and Carpenter Technology (CRS)

TIPRANKS
·
May 04

KeyBanc Sticks to Their Buy Rating for Carpenter Technology (CRS)

TIPRANKS
·
May 04

Carpenter Technology price target raised to $470 from $465 at JPMorgan

TIPRANKS
·
Apr 30